|Videos|December 6, 2022
Regulatory Considerations for Cell & Gene Therapies
Author(s)PPD
The first segment of this five-part PPD Tech Talk series on A CMC Roadmap for Cell and Gene Therapies, Katherine Hanson, Ph.D., associate director at PPD Laboratory services, GMP Lab, discusses regulatory considerations for cell and gene therapies.
Related Content
Trending on Pharmaceutical Technology
1
Writing the Biological Script: Scaling DNA Manufacturing for the Next Generation of Therapeutics
2
FDA Approves Pfizer’s Breast Cancer Treatment
3
Pharma Fundamentals: Hold Times in Biopharmaceuticals
4
Biomanufacturing's Next Decade Will Be Won by Adaptability, Not Capacity
5